C791-0265 Screening compound: N-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide

C791-0265 Screening compound: N-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide
C791-0265 Screening compound: N-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C791-0265
N-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C791-0265

Molecular Formula

C19H21N5O2S (C19 H21 N5 O2 S)

Compound Name

N-(4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide

IUPAC name

N-(4-methyl-3-oxo-34-dihydro-2H-14-benzothiazin-6-yl)-4-(pyridin-2-yl)piperazine-1-carboxamide

SMILES

CN1c(cc(cc2)NC(N(CC3)CCN3c3ncccc3)=O)c2SCC1=O

InChI

InChI=1S/C19H21N5O2S/c1-22-15-12-14(5-6-16(15)27-13-18(22)25)21-19(26)24-10-8-23(9-11-24)17-4-2-3-7-20-17/h2-7,12H,8-11,13H2,1H3,(H,21,26)

InChI Key

QKSJEFDBYRNZMX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14795664

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

383.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.260

Distribution Coefficient, logD

2.251

Water Solubility, LogSw

-2.87

Polar Surface Area

52.897

Acid Dissociation Constant (pKa)

12.19

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

C791-0265 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS MPO Library (28609 compounds)

CNS Targets (44014 compounds)

Human Kinases Annotated Library (2415 compounds)

SmartTM Library (51161 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Ion Channels Focused Library (26372 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system
  • Nervous system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
  • Nervous system
  • Cardiovascular
Targets:
  • Kinases
  • Ion Channels

References: we are preparing a list of scientific research reports with C791-0265 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C791-0265?
Check Price and Availability of C791-0265, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C791-0265 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C791-0265
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C791-0265
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C791-0265 available by request